# FDA Inspection 1210731 - Eric Sicard, M.D. - June 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/eric-sicard-md/58835e8d-907f-40ca-9de8-19f740bdeec0
Source feed: FDA_Inspections

> FDA Inspection 1210731 for Eric Sicard, M.D. on June 16, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210731
- Company Name: Eric Sicard, M.D.
- Inspection Date: 2023-06-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1259987 - 2025-01-17](https://www.keypedia.com/records/fda_inspections/eric-sicard-md/fb45f5cc-68e9-4b4b-b3f0-34d113a91238)
- [FDA Inspection 1259987 - 2025-01-17](https://www.keypedia.com/records/fda_inspections/eric-sicard-md/1947c57e-56ec-430e-9001-315f4bcafcca)

Company: https://www.keypedia.com/companies/eric-sicard-md/f2fda847-f1c8-4f59-8eed-2b40261d1075

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c